Cognitive Risk Stratification in Type 2 Diabetes: A Step Toward Early Detection - Top-Institutions - MDSpire

Cognitive Risk Stratification in Type 2 Diabetes: A Step Toward Early Detection

  • By

  • Aurelijus Burokas

  • Virginia Mela

  • February 19, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Endocrinology
    • Geriatrics
    • Cognitive Neuroscience

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Endocrinology
    • Epidemiology

  • #3

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neurology
    • Endocrinology
    • Neuropsychology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Endocrinology
    • Geriatrics

  • #5

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Neurology
    • Endocrinology
    • Neuroepidemiology

Original Source(s)

Cognitive Risk Stratification in Type 2 Diabetes: A Step Toward Early Detection

  • by Aurelijus Burokas, Virginia Mela

  • February 19, 2025

Related Content

Waist-to-height ratio for OSA risk: a comparative analysis of NHANES and a clinical data

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

The RASA2/RASA3 ortholog RasGAP1 modulates obesity-linked phenotypes and is associated with leptin-analog signaling in Drosophila